RMD 0.54% $37.28 resmed inc

oversold, page-95

  1. 8 Posts.
    as a long term shareholder of RMD my observation relates to its recent SAAS investments. before those it had a small debt level of circa 250m. it now has a debt level of circa 1.5b. this debt was borrowed to fund the SAAS business which dont appear adding accretive profit. EPS reflects this. shareholders now own a company with gross assets of over 3b whereas before they owned a company with gross assets of 2b .. with roughly the same earnings. effectively shareholders own a company that is 1/3 software company. before that it was no 1 or 2 (v philips) in the sleep apnea business with an enviable track record. it seems the business model has expanded from its core, paid a lot to do so and shareholders will be hoping this strategy works out. risk profile appears to have stepped up imo. i also cant find any announcements about these mayor decisions. this may be due US disclosure rules being different but thats not helpful. interested in others thoughts.
 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$37.28
Change
0.200(0.54%)
Mkt cap ! $22.38B
Open High Low Value Volume
$37.50 $37.55 $37.15 $17.93M 480.5K

Buyers (Bids)

No. Vol. Price($)
1 3363 $37.27
 

Sellers (Offers)

Price($) Vol. No.
$37.30 1001 2
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.